RSI spoločnosti Beam Therapeutics
Aká je hodnota metriky RSI spoločnosti Beam Therapeutics?
Hodnota metriky RSI spoločnosti Beam Therapeutics Inc. je 43.55
Aká je definícia metriky RSI?
Index relatívnej sily (Relative strength index - RSI 14) je technický ukazovateľ, ktorý sa radí medzi momentum indikátory a meria rýchlosť a zmenu ceny. Jeho hodnota sa pohybuje medzi 0 a 100 a používa sa na charakterizovanie prekupovaného a prepredaného stavu.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Beam Therapeutics
Čomu sa venuje spoločnosť Beam Therapeutics?
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Firmy s metrikou rsi podobnou spoločnosti Beam Therapeutics
- Hodnota metriky RSI spoločnosti Buru je 43.53
- Hodnota metriky RSI spoločnosti Samkrg Pistons and Rings je 43.53
- Hodnota metriky RSI spoločnosti New Leaf Ventures Inc je 43.54
- Hodnota metriky RSI spoločnosti Scholar Rock Corp je 43.54
- Hodnota metriky RSI spoločnosti East West je 43.54
- Hodnota metriky RSI spoločnosti Yield Go je 43.54
- Hodnota metriky RSI spoločnosti Beam Therapeutics je 43.55
- Hodnota metriky RSI spoločnosti Coeur Mining Inc je 43.56
- Hodnota metriky RSI spoločnosti Upland Resources je 43.56
- Hodnota metriky RSI spoločnosti ArcPacific Resources je 43.56
- Hodnota metriky RSI spoločnosti 1+1 Ag Inh O.N je 43.56
- Hodnota metriky RSI spoločnosti Keyne Ltd je 43.56
- Hodnota metriky RSI spoločnosti ZCCM Investments Plc je 43.56